Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP472472.RAv1ic0WxjiUHiygqnZnREdc_ytUyyA8a7Ituad-o_gPs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP472472.RAv1ic0WxjiUHiygqnZnREdc_ytUyyA8a7Ituad-o_gPs130_assertion type Assertion NP472472.RAv1ic0WxjiUHiygqnZnREdc_ytUyyA8a7Ituad-o_gPs130_head.
- NP472472.RAv1ic0WxjiUHiygqnZnREdc_ytUyyA8a7Ituad-o_gPs130_assertion description "[Moreover, expression studies showed that, during human development, SLC25A22 is specifically expressed in the brain, within territories proposed to contribute to the genesis and control of myoclonic seizures.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP472472.RAv1ic0WxjiUHiygqnZnREdc_ytUyyA8a7Ituad-o_gPs130_provenance.
- NP472472.RAv1ic0WxjiUHiygqnZnREdc_ytUyyA8a7Ituad-o_gPs130_assertion evidence source_evidence_literature NP472472.RAv1ic0WxjiUHiygqnZnREdc_ytUyyA8a7Ituad-o_gPs130_provenance.
- NP472472.RAv1ic0WxjiUHiygqnZnREdc_ytUyyA8a7Ituad-o_gPs130_assertion SIO_000772 15592994 NP472472.RAv1ic0WxjiUHiygqnZnREdc_ytUyyA8a7Ituad-o_gPs130_provenance.
- NP472472.RAv1ic0WxjiUHiygqnZnREdc_ytUyyA8a7Ituad-o_gPs130_assertion wasDerivedFrom befree-2016 NP472472.RAv1ic0WxjiUHiygqnZnREdc_ytUyyA8a7Ituad-o_gPs130_provenance.
- NP472472.RAv1ic0WxjiUHiygqnZnREdc_ytUyyA8a7Ituad-o_gPs130_assertion wasGeneratedBy ECO_0000203 NP472472.RAv1ic0WxjiUHiygqnZnREdc_ytUyyA8a7Ituad-o_gPs130_provenance.